{
    "Trade/Device Name(s)": [
        "N Latex CDT Kit"
    ],
    "Submitter Information": "Dade Behring Marburg GmbH",
    "510(k) Number": "K060677",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992502"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "NAO"
    ],
    "Summary Letter Date": "August 25, 2006",
    "Summary Letter Received Date": "July 13, 2006",
    "Submission Date": "July 12, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1360"
    ],
    "Regulation Name(s)": [
        "Gamma-glutamyl transpeptidase and isoenzymes test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbohydrate-deficient transferrin (CDT)",
        "Transferrin"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BN\u2122 II",
        "BN ProSpec\u00ae System"
    ],
    "Method(s)/Technology(ies)": [
        "Particle-enhanced immunonephelometry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for N Latex CDT Kit for quantitative measurement of carbohydrate-deficient transferrin in human serum using particle-enhanced immunonephelometry.",
    "Indications for Use Summary": "In vitro diagnostic for quantitative determination of carbohydrate-deficient transferrin (%CDT) in human serum using particle-enhanced immunonephelometry as a tool to identify possible chronic heavy alcohol consumption.",
    "fda_folder": "Clinical Chemistry"
}